nicotinamides were accomplished. Fifty-five functionalized nicotinamides of 7 types were rationally designed and efficiently prepared through C-H functionalization, which facilitated the acquirement of four N-para aryloxylated nicotinamides (E3, E13, E19, and E22) as potential antifungal candidates against Botrytis cinerea, with the EC50 values lower than 5 mg/L. In vivo/vitro biotest, molecular docking, and structural
受
琥珀酸脱氢酶
抑制剂成功成功修饰的鼓舞,进行了以预先验证的药效基团2-(2-
恶唑啉基)
苯胺的烟
酰胺的不同合成为指导的抗真菌活性。这项工作强调了先天性药效团协助后期CH功能化的首次利用,以发现有前途的农用
化学品。完成了新的合成方法和烷
氧基化烟
酰胺的抗真菌探索。通过CH官能化,合理设计和有效制备了7种类型的55种功能化烟
酰胺,并通过
EC50促进获得了四种N-对芳
氧基化烟
酰胺(E3,E13,E19和
E22)作为潜在的抗灰葡萄孢菌的抗真菌候选物。值低于5 mg / L。体内/体外
生物测试,分子对接和结构分析再次证实了抗真菌候选药物E3和E19的新颖性和实用潜力。这个操作简单的平台将提供各种“极性部分”,并为优化羧
酰胺类
杀菌剂和与结构有关的药物提供了诱人的机会。